Mgr. David Potěšil, Ph.D.
Deputy Core Facility Leader, Proteomics Core Facility
Office: bldg. E26/107b
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8426 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 208
2014
-
No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia
Hematological Oncology, year: 2014, volume: 32, edition: 2, DOI
-
Proteomics analysis of cell surface proteins associated with migration of MDA-MB-231 breast cancer cells
Year: 2014, type: Conference abstract
-
The protein composition of excretory-secretory products of three Trichinella species
Year: 2014, type: Conference abstract
-
Úloha transgelinu v migraci a apoptóze buněk
Year: 2014, type: Conference abstract
2013
-
Analysis of cell surface proteome of two variants of MDA-MB 231 breast cancer cells with different migration properties
Year: 2013, type: Conference abstract
-
Apoptosis in chronic myeloid leukemia cells transiently treated with imatinib or dasatinib is caused by residual BCR-ABL kinase inhibition.
American Journal of Hematology, year: 2013, volume: 88, edition: 5, DOI
-
ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin
Haematologica, year: 2013, volume: 98, edition: 7, DOI
-
Ferrous iron oxidation by sulfur-oxidizing Acidithiobacillus ferrooxidans and analysis of the process at the levels of transcription and protein synthesis
Antonie van Leeuwenhoek International Journal of General and Molecular Microbiology, year: 2013, volume: 103, edition: 4, DOI
-
Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs
RNA, year: 2013, volume: 19, edition: 12, DOI
-
Multiple roles of cytoskeletal proteins transgelins in breast cancer development and metastasis
Year: 2013, type: Conference abstract